DGX Quest Diagnostics: יחס שווי שוק לערך בספרים

Quest Diagnostics demonstrates resilience to economic fluctuations due to stable demand for diagnostics. The current ratio of the company's value to its book capitalization on the GURU.Markets consolidated chart shows that the 3.48 indicator expresses the state of the metric. Jim Davis's strategy relies on the acquisition of local laboratories, while the implementation of ESG standards optimizes medical waste processing.

For Quest Diagnostics (DGX), stable demand for laboratory testing and insurance reimbursements form an asset base that the market evaluates through the lens of capital management efficiency. By analyzing the company's market-to-book ratio, an investor determines the market price premium over the value of net assets, where an increasing value signals confidence in future earnings but elevates the risk of a correction.